Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 6,226–6,250 of 7,816 matching trials · page 250 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Mobile Phone App for Depression and Anxiety in Young Men Who Are Attracted to Men NCT02072252 Mobile Phone Application Runs in: United States · 1 site |
PHASE1|PHASE2 other |
WITHDRAWN | 0 | Northwestern University OTHER |
2017-08-17 |
|
Amantadine for the Treatment of Behavioral Disturbance in Frontotemporal Dementia (FTD) NCT00127114 Amantadine; Placebo Runs in: United States · 1 site |
PHASE4 other |
WITHDRAWN | 0 | Johns Hopkins University OTHER |
2017-08-14 |
|
Efficacy and Safety of Ramelteon in Subjects With Mild to Moderate Alzheimer's Disease NCT00325728 Ramelteon; Placebo Runs in: United States · 72 sites |
PHASE2 other |
COMPLETED | 74 | Takeda INDUSTRY |
2017-08-14 |
|
Characterisation of Primary Progressives Aphasias NCT02297035 Behavioural testing; Brain imaging; Genetic screening Runs in: France · 1 site |
NA other |
UNKNOWN | 155 | Assistance Publique - Hôpitaux de Paris OTHER |
2017-08-14 |
|
The Cognitive Resilience Study NCT03016702 Cognitive stress tests during functional MRI; Cognitive stress test... Runs in: United States · 1 site |
NA other |
COMPLETED | 29 | Duke University OTHER |
2017-08-14 |
|
Care Delivery in Acute Hospital Settings: an Observational Study NCT02212353 Observational study, not interventional |
NA other |
COMPLETED | 180 | University of East Anglia OTHER |
2017-08-11 |
|
Dose-ranging Safety and Tolerability Study in Subjects ≥60 Years of Age NCT02576639 CNP520; Placebo Runs in: Belgium; Germany; Netherlands; United Kingdom; United States · 11 sites |
PHASE2 other |
COMPLETED | 124 | Novartis Pharmaceuticals INDUSTRY |
2017-08-11 |
|
Sleep Bundle for Improving Sleep in ICU Patients NCT03247062 Quality improvement - sleep bundle |
NA other |
UNKNOWN | 130 | University Hospital, Geneva OTHER |
2017-08-11 |
|
Evaluation of the Animal Intervention Used as Therapy NCT02829801 AAT and cognitive stimulation and rehabilitation of social tie.; Co... Runs in: France · 1 site |
NA other |
UNKNOWN | 40 | Hospices Civils de Lyon OTHER |
2017-08-09 |
|
Development of a New Neuroimaging Method Aimed to Differentiate Mnesic Abilities of Alzheimer and Depressed Patients NCT02840045 high-density electroencephalography Runs in: France · 1 site |
NA other |
UNKNOWN | 30 | Centre Hospitalier Universitaire de Besancon OTHER |
2017-08-09 |
|
CPC-201 Alzheimer's Disease Type Dementia: PET Study NCT02860065 CPC-201; Positron emission tomography (PET) Runs in: United States · 1 site |
PHASE2 other |
WITHDRAWN | 0 | Chase Pharmaceuticals Corporation, an affiliate of Allergan plc INDUSTRY |
2017-08-09 |
|
FuRST 2.0 Cognitive Pre-Testing NCT02881931 FuRST 2.0 Runs in: Canada; United States · 4 sites |
NA other |
COMPLETED | 75 | CHDI Foundation, Inc. OTHER |
2017-08-08 |
|
Daily Sleep Enhancement for Hospitalized People With Dementia Following a Nursing Protocol NCT02953574 daily sleep enhancement nursing protocol |
NA other |
COMPLETED | 40 | University of Zurich OTHER |
2017-08-08 |
|
A Study To Demonstrate The Bioequivalence Of Rosiglitazone XR (BRL-049653) 8mgs XR Manufactured At Two Different Sites. NCT00468897 RSG XR Runs in: Germany · 1 site |
PHASE1 other |
COMPLETED | 50 | GlaxoSmithKline INDUSTRY |
2017-08-07 |
|
Brain-Computer Interface System for Training Memory and Attention in Elderly NCT02228187 Brain-Computer Interface Runs in: Singapore · 1 site |
PHASE2 other |
COMPLETED | 240 | Duke-NUS Graduate Medical School OTHER |
2017-08-02 |
|
Randomized Trial of Low-dose Naproxen in Cognitively Intact Persons at Risk of Alzheimer's Dementia NCT02702817 Naproxen; Placebo Runs in: Canada · 1 site |
PHASE2 other |
COMPLETED | 200 | Douglas Mental Health University Institute OTHER |
2017-08-01 |
|
OmegAD (Omega-3 and Alzheimer's Disease) NCT00211159 EPAX 1050TG Runs in: Sweden · 1 site |
NA other |
COMPLETED | 204 | Karolinska University Hospital OTHER |
2017-07-31 |
|
Eye Movement Recording as an Early Differential Diagnostic Tool for Alzheimer/Depression NCT01434940 Eye movements will be recorded using video-oculography techniques b... Runs in: France · 1 site |
NA other |
UNKNOWN | 288 | Centre Hospitalier Universitaire de Besancon OTHER |
2017-07-31 |
|
Effects of Simvastatin on Biomarkers NCT01142336 Simvastatin; Placebo Runs in: United States · 1 site |
PHASE4 other |
COMPLETED | 49 | University of Washington OTHER |
2017-07-28 |
|
Effects of Dietary Interventions on the Brain in Mild Cognitive Impairment (MCI) NCT01219244 caloric restriction; omega-3 supplementation; resveratrol supplemen... Runs in: Germany · 1 site |
PHASE2|PHASE3 other |
COMPLETED | 330 | Charite University, Berlin, Germany OTHER |
2017-07-28 |
|
Staccato Loxapine in Agitated Patients With Schizophrenia NCT00628589 Inhaled loxapine 5 mg; Inhaled loxapine 10 mg; Inhaled placebo Runs in: United States · 1 site |
PHASE3 other |
COMPLETED | 344 | Alexza Pharmaceuticals, Inc. UNKNOWN |
2017-07-26 |
|
Staccato Loxapine in Agitated Patients With Bipolar Disorder NCT00721955 Inhaled Placebo; Inhaled loxapine 5 mg; Inhaled loxapine 10 mg Runs in: United States · 6 sites |
PHASE3 other |
COMPLETED | 314 | Alexza Pharmaceuticals, Inc. UNKNOWN |
2017-07-26 |
|
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology NCT01886820 [18F]NAV4694 Runs in: United States · 15 sites |
PHASE3 other |
UNKNOWN | 290 | Navidea Biopharmaceuticals INDUSTRY |
2017-07-26 |
|
Clinical Pathway for Alzheimer's Disease in China (CPAD) NCT01779310 Runs in: China · 28 sites |
NA other |
COMPLETED | 1,024 | Peking University OTHER |
2017-07-25 |
|
Ketamine Versus Haloperidol for Severe Agitation Outside the Hospital NCT02103881 Ketamine; Haloperidol |
PHASE4 other |
WITHDRAWN | 0 | Hennepin Healthcare Research Institute OTHER |
2017-07-24 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial